182 related articles for article (PubMed ID: 21474662)
21. Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("ecstasy").
Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Menge M; Schulte Am Esch J
Anesthesiology; 2003 Nov; 99(5):1132-6. PubMed ID: 14576550
[TBL] [Abstract][Full Text] [Related]
22. Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individuals.
Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
Eur J Anaesthesiol; 2010 Jan; 27(1):77-82. PubMed ID: 19809329
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic and metabolic manifestations of acute endotoxin infusion in pigs with and without the malignant hyperthermia mutation.
Musley SK; Beebe DS; Komanduri V; Iaizzo PA; Belani KG
Anesthesiology; 1999 Sep; 91(3):833-8. PubMed ID: 10485795
[TBL] [Abstract][Full Text] [Related]
24. Malignant hyperthermia phenotype: hypotension induced by succinylcholine in susceptible swine.
Sigg DC; Iaizzo PA
Anesthesiology; 2000 Jun; 92(6):1777-88. PubMed ID: 10839930
[TBL] [Abstract][Full Text] [Related]
25. Atypical reactions to halothane in a subgroup of homozygous malignant hyperthermia(MH)-susceptible pigs: indication of a heterogenous genetic basis for the porcine syndrome.
Richter A; Gerdes C; Löscher W
Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):401-6. PubMed ID: 1425316
[TBL] [Abstract][Full Text] [Related]
26. Desflurane is a trigger of malignant hyperthermia in susceptible swine.
Wedel DJ; Iaizzo PA; Milde JH
Anesthesiology; 1991 Mar; 74(3):508-12. PubMed ID: 1900398
[TBL] [Abstract][Full Text] [Related]
27. Porcine malignant hyperthermia susceptibility: halothane-induced increase in cytoplasmic free calcium in lymphocytes.
O'Brien PJ; Kalow BI; Brown BD; Lumsden JH; Jacobs RM
Am J Vet Res; 1989 Jan; 50(1):131-5. PubMed ID: 2919818
[TBL] [Abstract][Full Text] [Related]
28. [Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].
Gerbershagen MU; Wappler F; Fiege M; Weisshorn R; Kolodzie K; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):81-6. PubMed ID: 14767797
[TBL] [Abstract][Full Text] [Related]
29. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
Hackl W; Winkler M; Mauritz W; Steinbereithner K
Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
[TBL] [Abstract][Full Text] [Related]
30. Ondansetron-induced muscular contractures in malignant hyperthermia-susceptible individuals.
Johannsen S; Roewer N; Schuster F
Anesth Analg; 2012 Oct; 115(4):925-8. PubMed ID: 22696611
[TBL] [Abstract][Full Text] [Related]
31. Differential diagnosis of thyroid crisis and malignant hyperthermia in an anesthetized porcine model.
Shailesh Kumar MV; Carr RJ; Komanduri V; Reardon RF; Beebe DS; Iaizzo PA; Belani KG
Endocr Res; 1999 Feb; 25(1):87-103. PubMed ID: 10098596
[TBL] [Abstract][Full Text] [Related]
32. [Malignant hyperthermia and inositol phosphate metabolism in the heart and skeletal musculature].
Scholz J; Roewer N; Troll U; Patten M; Schmitz W; Scholz H; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):450-3. PubMed ID: 1786304
[TBL] [Abstract][Full Text] [Related]
33. Alterations of inositol polyphosphates in skeletal muscle during porcine malignant hyperthermia.
Tonner PH; Scholz J; Richter A; Löscher W; Steinfath M; Wappler F; Wlaz P; Hadji B; Roewer N; Schulte am Esch J
Br J Anaesth; 1995 Oct; 75(4):467-71. PubMed ID: 7488490
[TBL] [Abstract][Full Text] [Related]
34. Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
Gallant EM; Foldes FF; Rempel WE; Gronert GA
Anesth Analg; 1985 Jun; 64(6):601-6. PubMed ID: 4003778
[TBL] [Abstract][Full Text] [Related]
35. Response to succinylcholine in porcine malignant hyperthermia.
Iaizzo PA; Wedel DJ
Anesth Analg; 1994 Jul; 79(1):143-51. PubMed ID: 8010426
[TBL] [Abstract][Full Text] [Related]
36. In vitro effects of levosimendan on muscle of malignant hyperthermia susceptible and non-susceptible swine.
Schuster F; Johannsen S; Isbary S; Türkmeneli I; Roewer N
BMC Anesthesiol; 2018 Dec; 18(1):182. PubMed ID: 30509180
[TBL] [Abstract][Full Text] [Related]
37. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
38. The severity of sevoflurane-induced malignant hyperthermia.
Migita T; Mukaida K; Kobayashi M; Hamada H; Kawamoto M
Acta Anaesthesiol Scand; 2012 Mar; 56(3):351-6. PubMed ID: 22092278
[TBL] [Abstract][Full Text] [Related]
39. [Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia].
Gerbershagen MU; Fiege M; Weisshorn R; Kolodzie K; Wappler F
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Mar; 39(3):147-52. PubMed ID: 15042504
[TBL] [Abstract][Full Text] [Related]
40. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
Sudo RT; Nelson TE
J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
